Cargando…

Effects of methylphenidate in children with attention deficit hyperactivity disorder: a near-infrared spectroscopy study with CANTAB®

BACKGROUND: A wide range of evidence supports the methylphenidate (MPH)-induced enhancement of prefrontal cortex (PFC) functioning and improvements in behavioral symptoms in patients with attention deficit hyperactivity disorder (ADHD). Although working memory (WM) has been hypothesized to be impair...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuura, Naomi, Ishitobi, Makoto, Arai, Sumiyoshi, Kawamura, Kaori, Asano, Mizuki, Inohara, Keisuke, Fujioka, Tohru, Narimoto, Tadamasa, Wada, Yuji, Hiratani, Michio, Kosaka, Hirotaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298959/ https://www.ncbi.nlm.nih.gov/pubmed/25606052 http://dx.doi.org/10.1186/s13034-014-0032-5

Ejemplares similares

Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects
por: Fujioka, Toru, et al.
Publicado: (2016)

Default mode network in young male adults with autism spectrum disorder: relationship with autism spectrum traits
por: Jung, Minyoung, et al.
Publicado: (2014)

Decision making processes based on social conventional rules in early adolescents with and without autism spectrum disorders
por: Komeda, Hidetsugu, et al.
Publicado: (2016)

Long-term oxytocin administration improves social behaviors in a girl with autistic disorder
por: Kosaka, Hirotaka, et al.
Publicado: (2012)

Sex-different abnormalities in the right second to fourth digit ratio in Japanese individuals with autism spectrum disorders
por: Masuya, Yasuhiro, et al.
Publicado: (2015)

Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults
por: Fujioka, Toru, et al.
Publicado: (2016)

Increased Anterior Pelvic Angle Characterizes the Gait of Children with Attention Deficit/Hyperactivity Disorder (ADHD)
por: Naruse, Hiroaki, et al.
Publicado: (2017)

Episodic memory retrieval for story characters in high-functioning autism
por: Komeda, Hidetsugu, et al.
Publicado: (2013)

The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders
por: Okamoto, Yuko, et al.
Publicado: (2016)

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder
por: Safavi, Parvin, et al.
Publicado: (2016)

Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015)

The Effects of Methylphenidate on Decision Making in Attention-Deficit/Hyperactivity Disorder
por: DeVito, Elise E., et al.
Publicado: (2008)

The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
por: İsmi, Onur, et al.
Publicado: (2018)

The Association Between Attention-Deficit Hyperactivity Disorder, Injuries, and Methylphenidate
por: Shem-Tov, Sharon, et al.
Publicado: (2019)

New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
por: Pitzianti, Maria Bernarda, et al.
Publicado: (2020)

Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder
por: Shirafkan, Hoda, et al.
Publicado: (2020)

Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
por: Mandali, Alekhya, et al.
Publicado: (2021)

Pica in an Adolescent with Attention Deficit Hyperactivity Disorder responsive to Methylphenidate
por: Bourgou, Soumaya, et al.
Publicado: (2021)

Continuity in Methylphenidate Treatment of Adults With Attention-Deficit/Hyperactivity Disorder
por: Olfson, Mark, et al.
Publicado: (2007)

Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial
por: Kosaka, H, et al.
Publicado: (2016)

CANTAB object recognition and language tests to detect aging cognitive decline: an exploratory comparative study
por: Cabral Soares, Fernanda, et al.
Publicado: (2014)

THE EQUIVALENCE OF CANTAB AS A COGNITIVE FUNCTION MEASURE FOR CHINESE STROKE SURVIVORS: A PILOT STUDY
por: Li, Fanfan, et al.
Publicado: (2022)

Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
por: Nair, Rajasree, et al.
Publicado: (2009)

The Safety and Efficacy of Methylphenidate and Dexmethylphenidate in Adults with Attention Deficit/Hyperactivity Disorder
por: Sopko, Michael A., et al.
Publicado: (2010)

Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS)
por: Findling, Robert L., et al.
Publicado: (2014)

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder
por: Pagerols, Mireia, et al.
Publicado: (2018)

Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
por: Jaeschke, Rafał R., et al.
Publicado: (2021)

Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder?
por: Pereira Ribeiro, Johanne, et al.
Publicado: (2021)

Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder
por: Arnett, Anne B., et al.
Publicado: (2022)

David Carr-Locke, MA, MB BChir (Cantab), DRCOG, FRCP, FACG, FASGE, AGAF, NYSGEF
Publicado: (2019)

The subtleties of cognitive decline in multiple sclerosis: an exploratory study using hierarchichal cluster analysis of CANTAB results
por: Cabeça, Hideraldo Luis Souza, et al.
Publicado: (2018)

Distinctive Pattern of Cognitive Disorders During Multiple Sclerosis Relapse and Recovery Based on Computerized CANTAB Tests
por: Giedraitiene, Natasa, et al.
Publicado: (2019)

Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate
por: van der Schans, Jurjen, et al.
Publicado: (2015)

Social adjustment and family function after drug switch from IR-methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder
por: Chou, Wen-Jiun, et al.
Publicado: (2018)

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options
por: Hodgkins, Paul, et al.
Publicado: (2012)

Methylphenidate Transdermal System in Attention-Deficit Hyperactivity Disorder in Adolescentsy: Profile Report
por: Keating, Gillian M.
Publicado: (2012)

Risperidone Versus Methylphenidate in Treatment of Preschool Children With Attention-Deficit Hyperactivity Disorder
por: Arabgol, Fariba, et al.
Publicado: (2015)

Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia
por: Golubchik, Pavel, et al.
Publicado: (2014)

The effect of methylphenidate-OROS(®) on the narrative ability of children with attention-deficit hyperactivity disorder
por: Rausch, Tessa L., et al.
Publicado: (2017)

The effect of adding ferrous sulfate to methylphenidate on attention-deficit/hyperactivity disorder in children
por: Panahandeh, Gholamreza, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ct8gfpjd52143he1beq3kmoqok